Clinical Trial Update: ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

View source ↗

Summary

This ClinicalTrials.gov update describes the ARCTIC study from Duke University, a prospective set of trials investigating liquid biomarkers in androgen receptor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Adenocarcinoma
• Prostate Cancer

Snippet

Sponsor: Duke University | Conditions: Prostate Cancer, Prostate Adenocarcinoma | Status: RECRUITING